Literature DB >> 21907916

Cancer biomarkers: closer to delivering on their promise.

Lance A Liotta1, Emanuel Petricoin.   

Abstract

Taguchi et al. describe, in this issue of Cancer Cell, a quantitative comparative biomarker discovery approach that integrates animal lung cancer models with validation in well-controlled human clinical study sets. This approach overcomes many of the major barriers that have held back the field of cancer biomarkers in the past.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Year:  2011        PMID： 21907916      PMCID： PMC3783266          DOI： 10.1016/j.ccr.2011.08.021

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  10 in total

Review 1.  The human plasma proteome: history, character, and diagnostic prospects.

Authors:  N Leigh Anderson; Norman G Anderson
Journal:  Mol Cell Proteomics       Date:  2002-11       Impact factor: 5.911

Review 2.  Mass spectrometry-based proteomics.

Authors:  Ruedi Aebersold; Matthias Mann
Journal:  Nature       Date:  2003-03-13       Impact factor: 49.962

Review 3.  The blood peptidome: a higher dimension of information content for cancer biomarker discovery.

Authors:  Emanuel F Petricoin; Claudio Belluco; Robyn P Araujo; Lance A Liotta
Journal:  Nat Rev Cancer       Date:  2006-11-09       Impact factor: 60.716

4.  High resolution spiral CT for determining the malignant potential of solitary pulmonary nodules: refining and testing the test.

Authors:  Stefan Walbom Harders; Hans Henrik Madsen; Torben Riis Rasmussen; Henrik Hager; Finn Rasmussen
Journal:  Acta Radiol       Date:  2011-03-24       Impact factor: 1.990

5.  Smart hydrogel particles: biomarker harvesting: one-step affinity purification, size exclusion, and protection against degradation.

Authors:  Alessandra Luchini; David H Geho; Barney Bishop; Duy Tran; Cassandra Xia; Robert L Dufour; Clinton D Jones; Virginia Espina; Alexis Patanarut; Weidong Zhou; Mark M Ross; Alessandra Tessitore; Emanuel F Petricoin; Lance A Liotta
Journal:  Nano Lett       Date:  2007-12-13       Impact factor: 11.189

6.  Proteomics. Proteomics ponders prime time.

Authors:  Robert F Service
Journal:  Science       Date:  2008-09-26       Impact factor: 47.728

7.  Bring on the biomarkers.

Authors:  George Poste
Journal:  Nature       Date:  2011-01-13       Impact factor: 49.962

8.  Lung cancer signatures in plasma based on proteome profiling of mouse tumor models.

Authors:  Ayumu Taguchi; Katerina Politi; Sharon J Pitteri; William W Lockwood; Vitor M Faça; Karen Kelly-Spratt; Chee-Hong Wong; Qing Zhang; Alice Chin; Kwon-Sik Park; Gary Goodman; Adi F Gazdar; Julien Sage; Daniela M Dinulescu; Raju Kucherlapati; Ronald A Depinho; Christopher J Kemp; Harold E Varmus; Samir M Hanash
Journal:  Cancer Cell       Date:  2011-09-13       Impact factor: 31.743

9.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

Authors:  Thomas J Lynch; Daphne W Bell; Raffaella Sordella; Sarada Gurubhagavatula; Ross A Okimoto; Brian W Brannigan; Patricia L Harris; Sara M Haserlat; Jeffrey G Supko; Frank G Haluska; David N Louis; David C Christiani; Jeff Settleman; Daniel A Haber
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

10.  The preclinical natural history of serous ovarian cancer: defining the target for early detection.

Authors:  Patrick O Brown; Chana Palmer
Journal:  PLoS Med       Date:  2009-07-28       Impact factor: 11.069
  10 in total
  9 in total

1.  Translating cancer 'omics' to improved outcomes.

Authors:  Emily A Vucic; Kelsie L Thu; Keith Robison; Leszek A Rybaczyk; Raj Chari; Carlos E Alvarez; Wan L Lam
Journal:  Genome Res       Date:  2012-02       Impact factor: 9.043

Review 2.  Next-generation proteomics: towards an integrative view of proteome dynamics.

Authors:  A F Maarten Altelaar; Javier Munoz; Albert J R Heck
Journal:  Nat Rev Genet       Date:  2012-12-04       Impact factor: 53.242

3.  Molecular biomarkers in glaucoma.

Authors:  Sanjoy K Bhattacharya; Richard K Lee; Franz H Grus
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-07       Impact factor: 4.799

4.  Sequential Nucleophilic "Click" Reactions for Functional Amphiphilic Homopolymers.

Authors:  Huan He; Bin Liu; Meizhe Wang; Richard W Vachet; S Thayumanavan
Journal:  Polym Chem       Date:  2018-11-15       Impact factor: 5.582

Review 5.  Unleashing the power of proteomics to develop blood-based cancer markers.

Authors:  Ayumu Taguchi; Samir M Hanash
Journal:  Clin Chem       Date:  2012-10-24       Impact factor: 8.327

6.  Multinozzle emitter array chips for small-volume proteomics.

Authors:  Pan Mao; Rafael Gomez-Sjoberg; Daojing Wang
Journal:  Anal Chem       Date:  2012-12-21       Impact factor: 6.986

Review 7.  From drug discovery to biomarker-driven clinical trials in lymphoma.

Authors:  Anas Younes; Donald A Berry
Journal:  Nat Rev Clin Oncol       Date:  2012-09-11       Impact factor: 66.675

Review 8.  The biology of personalized cancer medicine: facing individual complexities underlying hallmark capabilities.

Authors:  Michele De Palma; Douglas Hanahan
Journal:  Mol Oncol       Date:  2012-02-04       Impact factor: 6.603

9.  Multicompartment modeling of protein shedding kinetics during vascularized tumor growth.

Authors:  Gautam B Machiraju; Parag Mallick; Hermann B Frieboes
Journal:  Sci Rep       Date:  2020-10-07       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.